Agios Pharmaceuticals AGIO Q3 2025 earnings
Reported October 30, 2025 · Before market open
Revenue$12.9MBeat by $1.2M
EPS-$1.78Beat by $0.15
Revenue estimate$11.7M
EPS estimate-$1.93
Next report
Jul 30, 2026 (Tomorrow)Revenue estimate$26.4M
EPS estimate-$1.65
Financials
Q3 2025Valuation & ratios
Versus estimates
Revenue
Diluted EPS
Ask the moment Agios Pharmaceuticals reports.
Connect your AI and ask the moment the filing drops. It reads the release, surfaces what management said, and gives you its own read.
Connect your AI
Claude
Questions, answered.
- When did Agios Pharmaceuticals report Q3 2025 earnings?
- Agios Pharmaceuticals (AGIO) reported Q3 2025 earnings on October 30, 2025 before market open.
- What were Agios Pharmaceuticals's Q3 2025 revenue and EPS?
- Agios Pharmaceuticals reported revenue of $12.9M and eps of $-1.78 for Q3 2025.
- Did Agios Pharmaceuticals beat estimates in Q3 2025?
- Revenue beat the consensus estimate of $11.7M by $1.2M. EPS beat the consensus estimate of $-1.93 by $0.15.
- How did Agios Pharmaceuticals's Q3 2025 results compare year-over-year?
- Compared to the same quarter a year prior, revenue grew 43.7% from $9.0M a year earlier.
- Where can I find Agios Pharmaceuticals's Q3 2025 SEC filings?
- You can read the 10-Q periodic report (0001439222-25-000116) directly on SEC EDGAR. The filing index links above go to sec.gov.